Being a human guinea pig

Drug development happens in stages – pre-clinical, phase I, II, III, and so on. But how much do trial participants know about what has happened before their enrolment to test for safety, and how much should they be told? Holger Pedersen from Denmark was one trial participant who tried to find information about the drug he was on, and was surprised at how little data had actually been collected, let alone shared – which has been detailed in an analysis article on thebmj.com He talks to Helen Macdonald, analysis editor for the BMJ about his experience. Read the analysis article: http://www.bmj.com/content/349/bmj.g6714